Evidence map›Paper›PMID 21980477›Full record

ArticlePloS one2011

Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice.

Andrey A Filippov, Kirill V Sergueev, Yunxiu He, Xiao-Zhe Huang, Bryan T Gnade, Allen J Mueller, Carmen M Fernandez-Prada, Mikeljon P Nikolich

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 189 citations in OpenAlex.

  1. Antibiotics (Basel, Switzerland) · 2026
    Article
  2. Anti-infective compounds forSustainable microbiology · 2026
    Review
  3. Three Novel Bacteriophages for the Biocontrol ofPathogens (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Abiotic environmental conditions determine phage resistance outcomes in a salt-marsh bacterium.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. microLife · 2025
    Article
  13. Article
  14. Review
  15. Multi-strain phage induced clearance of bacterial infections.bioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Does Phage Therapy Need a Pan-Phage?Pathogens (Basel, Switzerland) · 2024
    Review
  18. Article
  19. Potential of an Isolated Bacteriophage to InactivateAntibiotics (Basel, Switzerland) · 2024
    Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Andrey A FilippovDivision of Bacterial and Rickettsial Diseases, Department of Emerging Bacterial Infections, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America. andrey.filippov@amedd.army.mil
Kirill V Sergueev
Yunxiu He
Xiao-Zhe Huang
Bryan T Gnade
Allen J Mueller
Carmen M Fernandez-Prada
Mikeljon P Nikolich
Walter Reed Army Institute of Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBacteriophages specific for Yersinia pestis are routinely used for plague diagnostics and could be an alternative to antibiotics in case of drug-resistant plague. A major concern of bacteriophage therapy is the emergence of phage-resistant mutants. The use of phage cocktails can overcome this problem but only if the phages exploit different receptors. Some phage-resistant mutants lose virulence and therefore should not complicate bacteriophage therapy. METHODOLOGY/PRINCIPAL

findingsThe purpose of this work was to identify Y. pestis phage receptors using site-directed mutagenesis and trans-complementation and to determine potential attenuation of phage-resistant mutants for mice. Six receptors for eight phages were found in different parts of the lipopolysaccharide (LPS) inner and outer core. The receptor for R phage was localized beyond the LPS core. Most spontaneous and defined phage-resistant mutants of Y. pestis were attenuated, showing increase in LD₅₀ and time to death. The loss of different LPS core biosynthesis enzymes resulted in the reduction of Y. pestis virulence and there was a correlation between the degree of core truncation and the impact on virulence. The yrbH and waaA mutants completely lost their virulence. CONCLUSIONS/SIGNIFICANCE: We identified Y. pestis receptors for eight bacteriophages. Nine phages together use at least seven different Y. pestis receptors that makes some of them promising for formulation of plague therapeutic cocktails. Most phage-resistant Y. pestis mutants become attenuated and thus should not pose a serious problem for bacteriophage therapy of plague. LPS is a critical virulence factor of Y. pestis.

Indexed as

MutationAnimalsBacteriophagesFemaleLipopolysaccharidesMiceMutagenesis, Site-DirectedPlagueProtein TransportReceptors, VirusSpecies SpecificityYersinia pestisLipopolysaccharidesReceptors, Virus

Identifiers

PMID21980477
PMCPMC3182234
OpenAlexW2166199652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.